Philips Canada Launches New Full Featured and Cost-Effective Two-in-One Life Support Ventilator
May 29 2015 - 9:00AM
Business Wire
Advanced solution designed for smoother transition from invasive
to noninvasive ventilation
Royal Philips (NYSE: PHG, AEX: PHIA) today announced the
Canadian launch of the Philips Respironics V680 Ventilator for
hospital respiratory care, offering both invasive and noninvasive
ventilation. The Philips Respironics V680 Ventilator was recently
unveiled at the Canadian Society of Respiratory Therapists’ Annual
Conference in Calgary, Alberta.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20150529005102/en/
Discover Philips Respironics V680, the
simple, clinically advanced way to provide your patients with
reliable, high-performance ventilation across the continuum of
care. (Photo: Business Wire)
In consultation with clinicians, the Philips Respironics V680
Ventilator is designed for smoother transition from ventilation to
natural breathing, which may help enhance patient care. The Philips
Respironics V680 Ventilator joins Philips’ existing portfolio of
leading edge patient-centred hospital respiratory care solutions,
created to deliver higher quality and comfortable care.
“For nearly 125 years, Philips has been committed to delivering
innovations that improve people’s lives. The Philips Respironics
V680 Ventilator is yet another example of Philips technology that
is designed with the needs of both the patient and clinician in
mind,” said Iain Burns, President, Philips Canada. “From Healthy
Living, Prevention, Diagnosis, to Treatment, Recovery and Home
Care, Philips creates solutions that span the health continuum, and
it’s how we are delivering on our vision to make the world
healthier through innovation.”
The Philips Respironics V680 Ventilator is the first ventilator
to combine the Philips gold standard single-limb noninvasive
ventilation (NIV) solution with a fully featured, dual-limb system.
Designed to deliver advanced life support for critically ill
patients in the Intensive Care Unit (ICU), the Philips Respironics
V680 Ventilator is also designed to make it fast and easy to switch
from invasive to noninvasive ventilation to streamline transitions.
Personalized to each patient, the Philips Respironics V680
Ventilator can help deliver the right therapy at the right time.
The Philips Respironics V680 Ventilator is the only ventilator to
provide continuous measurements of dynamic resistance, compliance,
elastance, and plateau pressure in both single and dual-limb
invasive and noninvasive modes.
“Noninvasive therapy has become the first line of therapy for
many patients presenting with respiratory distress,” commented
Thomas Piraino, RRT, FCSRT, Best Practice Clinical Educator
and Assistant Clinical Professor (Adjunct) for McMaster
University. “In my opinion, the BiPAP Vision, and the
current V60 have always been the gold standard for the noninvasive
treatment of acute respiratory distress. The ability to deliver
invasive mechanical ventilation for the patient unable to improve,
or be managed with noninvasive therapy is what makes the V680
ventilator a compelling product for critical care and
emergency departments, or as a primary mechanical ventilator in the
community hospital setting.”
NIV has become a standard of care for the management of acute
respiratory failure, but there is a risk of leaks around the mask
that may interfere with ventilator performance. As a result,
patient-ventilator asynchrony, defined as a mismatch between
patient's inspiratory time and the ventilator insufflation time,
may occur in nearly 25 per cent of intubated patients.1 These high
rates of asynchrony can be associated with a higher incidence of
weaning failure and tracheostomy, prolonged mechanical ventilation,
fatigue, increased sedation needs and longer hospital stays.1
A recent study to compare patient-ventilator synchrony during
NIV between ICU, transport and dedicated NIV ventilators, found the
use of a NIV ventilator on critically ill patients led to a
significant decrease in the incidence of patient-ventilator
asynchrony.2 Moreover, dedicated NIV ventilators exhibited more
standardised behaviour during the investigation, with an ability to
avoid auto-triggering or delayed cycling while keeping a short
triggering delay despite the presence of leaks.2
The Philips Respironics V680 Ventilator joins Philips’ existing
portfolio of patient-centred hospital respiratory care solutions
which includes the Philips Respironics V60; the Philips gold
standard hospital dedicated noninvasive ventilator.
The Philips Respironics V680 Ventilator is now available in
Canada and several European markets. US launch is pending 510(k)
clearance.
For more information on the Philips Respironics V680 Critical
Care Ventilator please visit:
http://www.philips.ca/healthcare-product/HCNOCTN323/respironics-v680
and follow the conversation on Twitter @PhilipsHealth.
About Royal Philips:Royal Philips (NYSE: PHG, AEX: PHIA)
is a diversified health and well-being company, focused on
improving people’s lives through meaningful innovation in the areas
of Healthcare, Consumer Lifestyle and Lighting. Headquartered in
the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and
employs approximately 108,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions
and new lighting applications, as well as male shaving and grooming
and oral healthcare. News from Philips is located at
www.philips.com/newscenter.
References:
1 Bitando et al. Patient-ventilator asynchrony during
conventional or automated pressure support ventilation in
difficult-to-wean patients. Critical Care 2012, 16(Suppl 1):P1262
Carteaux et al. Patient-Ventilator Asynchrony During Noninvasive
Ventilitation. Chest 2012; 142(2): p. 367-376.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150529005102/en/
Philips CanadaSantina Giuliano, +1
905-201-4196santina.giuliano@philips.com
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (NYSE:PHG)
Historical Stock Chart
From Apr 2023 to Apr 2024